Julie Burgess - 01 Oct 2021 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Chief Accounting Officer
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol
DSGN
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
4
Filing time
04 Oct 2021, 16:53:44 UTC
Previous filing
20 Sep 2021
Next filing
02 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DSGN Stock Option (right to buy) Award $0 +135,000 $0.000000 135,000 01 Oct 2021 Common Stock 135,000 $14.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares vest one year after September 13, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.